Navigation Links
American College of Rheumatology presents recommendations for rheumatoid arthritis therapy
Date:6/3/2008

To manage the painful and incapacitating symptoms of rheumatoid arthritis (RA), a chronic, inflammatory joint disease, the majority of patients rely on disease-modifying antirheumatic drugs (DMARDs). In addition to trusted nonbiologic DMARDs, a number of biologic agents now promise to improve treatment for RA. The American College of Rheumatology (ACR), respected worldwide for its devotion to fostering excellence in patient care, has not updated recommendations for non-biologic DMARDs since 2002 and has not previously developed recommendations for biologic agents. In view of that, ACR decided it was time for a major re-evaluation of the use of DMARD therapy in rheumatoid arthritis.

Under the guidance of a Core Expert Panel of clinicians and methodologists and based on a systematic review of the scientific evidence, a second group of internationally recognized clinicians, methodologists, and patient representatives with extensive expertise in the use of nonbiologic and biologic DMARDs developed these recommendations for the ACR and the results of their work will be presented in the June 2008 issue of Arthritis Care & Research (www.interscience.wiley.com/journal/arthritis). These recommendations on the use of non-biologic and biologic DMARDs in RA address 5 key areas pre-specified by the ACR: indications for use, monitoring for side-effects, assessing the clinical response, screening for tuberculosis (a risk factor associated with biologic DMARDs), and under certain circumstances (i.e. high disease activity) the roles of cost and patient preference in choosing biologic agents. When developing these recommendations, RA disease duration, disease severity, and prognostic features were also considered.

"These recommendations were developed for specialist clinicians familiar with assessing RA disease activity and disease severity," notes Kenneth Saag, M.D., Professor of Med
'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. American Italian Pasta Company Extends Line of Healthier Pastas With Heartland(R) Perfect Balance
2. American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
3. American Academy of Pediatrics Launches 2008 National Art Contest for Children
4. Animal Dermatology Clinic - San Diego Announces Dr. Brett Wildermuth, DVM, Achieves Diplomate Status With the American College of Veterinary Dermatology
5. Isis Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
6. American Oriental Bioengineering Announces US$75 Million Share Repurchase Program
7. Indiana University research at the American College of Sports Medicine annual conference
8. Jeff Bailet, M.D., Appointed to American Medical Associations Advisory Committee
9. American Lung Association of Iowa: Summer Camp Helps Kids With Asthma
10. Delisting Notification Received from the American Stock Exchange
11. American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... Manufacturers of natural ingredient beauty creams are now ... younger appearance. The Cherry News company has published its ... women explore the availabilities from U.S. retailers at ... the posted guide on the Cherry News website provide ... to some natural ingredient formulas is the high sticker ...
(Date:7/27/2014)... CA (PRWEB) July 27, 2014 Ticket Down ... Tickets at The Forum in Inglewood, California on November 15th. ... and diehard fans can expect to hear songs from this amazing ... of Summer concert in Inglewood, California at The Forum will be ... starting at 10:00 a.m. today local time TicketDown.com. This popular ...
(Date:7/27/2014)... 2014 The constant expansion of companies ... demand for enterprise video. Additional factors that have increased ... areas such as corporate communication, learning and development, security ... all these factors the enterprise video market value has ... reach $35.57 billion in 2018 with a compound annual ...
(Date:7/27/2014)... The report, “Oil Filter & Fuel Filter Market by ... (OE & Aftermarket), Filter Type (Oil & Fuel), Fuel ... & Forecast to 2018”, defines and segments the global ... forecasting of the global volume and revenue. The market ... revenue of $6.1 billion in 2018, while fuel filter ...
(Date:7/27/2014)... European Bromine market report defines and segments the Bromine market ... market in European region comprises of four major countries. They ... forms a dominant share of Bromine market influences the demand ... through the TOC of the Europe Bromine Market report, to ... the TOC of the Europe Bromine Market report. The report ...
Breaking Medicine News(10 mins):Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bromine Market is Expected to Reach $111.6 Million in 2018 - New Report by MicroMarket Monitor 4
... muscle, bone behind severity of damage, longer recovery, study finds ... muscles of the lower body appear to be more vulnerable ... new study suggests. , The study analyzed the weight and ... over a three-year period. Sprains, such as to the ankle ...
... ranked among the top competitors in the world for Biathlon competitions. As ... Games to be held in Vancouver, Canada. Lanny and Tracy are crediting ... helping them get the most out of their training. , ... Parsippany, ...
... from Sticky Jewelry make a difference. Sticky J attends the "Walk ... and the Juvenile Diabetes Research Foundation made the day a success. ... ... 2000 Sticky Jewelry (StickyJ.com) has specialized in selling personalized jewelry ...
... of swine flu casesBELIZE CITY, Belize, May 1 ... residents and travelers against the swine flu, which is now ... additional proactive steps towards protection against the pandemic. ... Zone and casinos in the town of Corozal, which borders ...
... SCARBOROUGH, Maine , May 1, Binax, ... diagnostic tests to identify the causative pathogens of infectious ... information has been distributed to customers and potential customers of ... of the BinaxNow(R) Influenza A & B test has not ...
... with cancer that is resistant to standard therapy is the ... obtained in some settings, in many cases the therapies have ... has now been uncovered by a team of researchers, led ... London School of Medicine and Dentistry, London. , In the ...
Cached Medicine News:Health News:Obese Children More Likely to Suffer Lower Body Injuries 2Health News:Twin Sisters Set Their Sights On Biathlon Gold At The 2010 Winter Games 2Health News:Sticky Jewelry & JDRF Team Up to Find a Cure 2Health News:Sticky Jewelry & JDRF Team Up to Find a Cure 3Health News:Belize Takes Further Action Regarding Influenza A (H1N1) to Ensure Safety of Travelers 2
(Date:7/25/2014)... 2014  Depomed, Inc. (NASDAQ: DEPO ) ... year 2014 financial results after the market closes on Wednesday, ... call beginning at 4:30 pm EDT, 1:30 pm PDT to discuss ... by dialing 877-317-6789 ( United States ) ... available via a live webcast on the investor relations ...
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... WOONSOCKET, R.I. , July 25, 2014  CVS ... holding a conference call on Tuesday, August 5, 2014, ... discuss its second quarter 2014 financial results. ... broadcast simultaneously through the Investor Relations portion of the ... the webcast, visit http://info.cvscaremark.com/investors . This webcast will ...
Breaking Medicine Technology:Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
... YORK , June 21 Pfizer Inc. (NYSE: ... and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® ... leukemia (AML)) in the United States and that it will ... October 15, 2010 . , , ...
... , MONTEREY, Calif. , June 21 ... Cayston delivered by the Altera Nebulizer System versus tobramycin ... aeruginosa , the co-primary endpoint of non-inferiority for mean ... (FEV(1)) percent predicted after 28 days of treatment was ...
Cached Medicine Technology:Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 2Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 3Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 4Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 5Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 6PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 2PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 3PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution 4
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Anatomical implants for the entire hand, in five sizes...
... a brief magnetic pulse to stimulate deep ... in Magnetic Nerve Stimulators. Based upon equipment ... in 1985. A powerful monophasic stimulator for ... best stimulator for Central Motor Conduction Studies, ...
Medicine Products: